SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
Clinical trials for SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS explained in plain language.
Never miss a new study
Get alerted when new SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS trials appear
Sign up with your email to follow new studies for SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug targets deadly immune storm in rare inflammatory diseases
Disease control CompletedThis study tested a drug called emapalumab in 33 children and adults with a dangerous immune overreaction (macrophage activation syndrome) caused by Still's disease or lupus. The goal was to see if the drug could calm the immune system and improve blood test results when standard…
Matched conditions: SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
Phase: PHASE3 • Sponsor: Swedish Orphan Biovitrum • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Promising combo tackles rare immune storm in adults
Disease control CompletedThis study tested a combination of two drugs—interferon-gamma monoclonal antibody and dexamethasone—in 22 adults with a severe immune condition called refractory secondary HLH. The goal was to see if the treatment could help patients recover and how safe it was. Participants rece…
Matched conditions: SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
Sponsor: Fudan University • Aim: Disease control
Last updated May 22, 2026 13:52 UTC